[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Kofinas et al., 2015 - Google Patents

Serum progesterone levels greater than 20 ng/dl on day of embryo transfer are associated with lower live birth and higher pregnancy loss rates

Kofinas et al., 2015

View HTML
Document ID
14182609494024513742
Author
Kofinas J
Blakemore J
McCulloh D
Grifo J
Publication year
Publication venue
Journal of assisted reproduction and genetics

External Links

Snippet

Background Progesterone (P4) is essential for support of the endometrium and implantation of an embryo in the normal menstrual cycle. In programed frozen embryo transfer cycles using exogenous P4 is necessary, as the endogenous production of P4 requires a …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs

Similar Documents

Publication Publication Date Title
Kofinas et al. Serum progesterone levels greater than 20 ng/dl on day of embryo transfer are associated with lower live birth and higher pregnancy loss rates
Junk et al. Improved implantation and ongoing pregnancy rates after single-embryo transfer with an optimized protocol for in vitro oocyte maturation in women with polycystic ovaries and polycystic ovary syndrome
Kaser et al. Intramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support for day 3 cryopreserved embryo transfer
Edwards IVF, IVM, natural cycle IVF, minimal stimulation IVF–time for a rethink
Weghofer et al. Lack of association between polycystic ovary syndrome and embryonic aneuploidy
Rodriguez-Purata et al. Reproductive outcome is optimized by genomic embryo screening, vitrification, and subsequent transfer into a prepared synchronous endometrium
Hancke et al. Patients undergoing frozen-thawed embryo transfer have similar live birth rates in spontaneous and artificial cycles
Bakircioglu et al. Klinefelter syndrome: does it confer a bad prognosis in treatment of nonobstructive azoospermia?
McAvey et al. How many eggs are needed to produce an assisted reproductive technology baby: is more always better?
Halvaei et al. The effect of immature oocytes quantity on the rates of oocytes maturity and morphology, fertilization, and embryo development in ICSI cycles
Anderson et al. Clinical benefits of preimplantation genetic testing for aneuploidy (PGT-A) for all in vitro fertilization treatment cycles
Litwicka et al. HCG administration after endogenous LH rise negatively influences pregnancy rate in modified natural cycle for frozen–thawed euploid blastocyst transfer: a pilot study
Melnick et al. Replacing single frozen-thawed euploid embryos in a natural cycle in ovulatory women may increase live birth rates compared to medicated cycles in anovulatory women
Ashkenazi et al. The role of purified follicle stimulating hormone therapy in the male partner before intracytoplasmic sperm injection
Drakopoulos et al. Does the type of GnRH analogue used, affect live birth rates in women with endometriosis undergoing IVF/ICSI treatment, according to the rAFS stage?
Damario et al. Pronuclear stage cryopreservation after intracytoplasmic sperm injection and conventional IVF: implications for timing of the freeze
Ji et al. Effect of embryo developmental stage, morphological grading, and ploidy status on live birth rate in frozen cycles of single blastocyst transfer
Yang et al. Euploidy rates among preimplantation genetic testing for aneuploidy cycles with oral dydrogesterone primed ovarian stimulation or GnRH antagonist protocol
Jiang et al. Short (seven days) versus standard (fourteen days) oestrogen administration in a programmed frozen embryo transfer cycle: a retrospective cohort study
Benkhalifa et al. Natural cycle IVF and oocyte in-vitro maturation in polycystic ovary syndrome: a collaborative prospective study
Orvieto et al. Results of in vitro fertilization cycles in women aged 43–45 years
Cardellicchio et al. Frozen–thawed blastocyst transfer in natural cycle: feasibility in everyday clinical practice
Elizur et al. Comparison of low-dose human menopausal gonadotropin and micronized 17β-estradiol supplementation in in vitro maturation cycles with thin endometrial lining
Lattes et al. A freeze-all strategy does not increase live birth rates in women of advanced reproductive age
Guerrero et al. Random-start ovarian stimulation in an oocyte donation programme: a large, single-centre, experience